NVDA+2.54%AAPL+1.32%GOOGL−1.62%MSFT+0.20%AMZN−0.10%TSM+1.60%SPCX+7.79%META+0.47%
StockVS

NASDAQ · Medical Devices · USD

Nuwellis, Inc. (NUWE) Stock Analysis

Nuwellis, Inc. (NUWE) is a Medical Devices stock listed on NASDAQ and quoted in US Dollar.

Last Updated: October 21, 2026

NUWE

$0.52

−$0.03 (−5.08%)

Oct 21, 2026 · Market close

Compare

Price History

Hover for the daily close. The dotted line marks the period open.

Compare NUWE with… →

NUWE Key Statistics

As of Oct 21, 2026
Trading
Open
$0.56
Previous Close
$0.55
Day's Range
0.52–0.56
52-Week Range
0.44–172.90
Volume
80.81K
BetaHow much the share price moves relative to the wider market. 1.0 moves in line with it; above 1.0 swings more, below 1.0 less.
0.09
Valuation
Market Cap
$1.90M
P/E Ratio
unprofitable
P/S ratioMarket value divided by annual revenue. Useful for companies that are not yet profitable, where a P/E cannot be calculated.
0.21
Financials (FY)
Revenue (FY)
$8.27M−5.38%
Net Income (FY)
−$17.52M
Profit marginThe share of revenue left as profit after all costs and taxes.
−125.63%
Shares OutstandingThe total number of shares held by all investors. Market value is this figure multiplied by the share price.
3.65M
1-Year Return
−83.70%
Dividend and dates
Earnings Date
November 11, 2026estimated
Avg Volume
4.33M

Only metrics the company reports are shown. Data provided by Yahoo Finance via yfinance. Updated daily.

Key facts

As of October 21, 2026, NUWE closed at $0.52, −83.70% over 1 year.

Nuwellis, Inc. (NUWE) has a market capitalization of $1.90M.

In fiscal 2025, NUWE reported revenue of $8.27M.

NUWE Stock Return by Calendar Year

Nuwellis, Inc. (NUWE) return since Jan 2025: what $10,000 became

1 year
$10,000 $1,630
−83.70%
Since Jan 2025
$10,000 $123
−98.77%

If you had invested $10,000 in Nuwellis, Inc. (NUWE) at the close on January 13, 2025, the earliest close on record here, it would have been worth $123 at the close on October 21, 2026: −98.77% in total, −91.68% a year, over a partial period shorter than 10 years. A historical calculation from closing prices adjusted for splits and dividends, before fees and taxes.

Calendar-year returns computed from daily closing prices. Partial years are shown muted and marked with an asterisk.

YearReturn
2026 (partial year)−70.02%
2025−95.90%

As of October 21, 2026.

NUWE Revenue and Earnings by Fiscal Year

FY ends December
Fiscal yearRevenueNet incomeNet margin
2025$8.27M−$17.52M−211.9%
2024$8.74M−$11.17M−127.7%
2023$8.86M−$20.21M−228.0%
2022$8.54M−$14.53M−170.0%
Fiscal yearRevenueGross profitOperating incomeNet incomeNet margin
2025$8.27M$5.12M−$11.11M−$17.52M−211.9%
2024$8.74M$5.68M−$10.99M−$11.17M−127.7%
2023$8.86M$4.98M−$17.63M−$20.21M−228.0%
2022$8.54M$4.76M−$17.17M−$14.53M−170.0%

Annual figures as reported, in the company's reporting currency. As of December 31, 2025.

NUWE Valuation vs Medical Devices Median

Median of 145 stocks
MetricNUWEMedical Devices medianvs median
P/S ratio0.212.530.1x the median
Profit margin−125.63%−14.78%110.9 pts below

Medians across 145 Medical Devices stocks that report the metric. Medians, not averages, so one outlier cannot move them. As of October 21, 2026.

Recent News

All 11 articles ↓

News provided by third-party sources. Not financial advice.

Analysis

Data-derived

Company Overview

The market values Nuwellis, Inc. (NUWE) at $1.90M. The company sits in the Healthcare sector, in the Medical Devices industry. The company reports 38 employees.

NUWE last closed at $0.52 on October 21, 2026. That is −$0.03 (−5.08%) against the previous close. Over the past 52 weeks the price has ranged from $0.44 to $172.90. The latest close sits 18.55% above that 52-week low.

Financial Health

Fiscal 2025 revenue came to $8.27M. That is −5.38% against the prior fiscal year, when revenue was $8.74M. The same year closed with a net loss of $17.52M. The reported profit margin is −125.63%. That is 110.9 percentage points below the Medical Devices median of −14.78%.

Across the 4 fiscal years on file, revenue moves from $8.54M in 2022 to $8.27M in 2025. Of those 4 years, 0 report positive net income.

Valuation Assessment

No trailing P/E applies: the last reported earnings figure is negative. The price-to-sales ratio is 0.21. On price-to-sales that is 0.1 times the Medical Devices median of 2.53. The medians here are taken across 145 Medical Devices companies that report the metric.

Over the trailing twelve months the total return is −83.70%. The stored price history starts on January 13, 2025, and the total return since then is −98.77%. Beta against the wider market is reported at 0.09. Annualized volatility over the trailing 1 year is 2,837.91%.

Growth & Income

The record shows no dividend for NUWE.

The record holds one complete calendar year, 2025, which returned −95.90%. 2026 is still running; the total return is −70.02% year to date.

Peer Comparison

Nuwellis, Inc. (NUWE) operates in the Medical Devices industry. Here is how it compares to its closest peers by market capitalization:

Company Ticker Market Cap P/E Ratio
Nuwellis, Inc. NUWE $1.90M —
Abbott Laboratories ABT $173.92B 32.4
Medtronic plc. MDT $119.00B 22.9
Stryker Corporation SYK $114.15B 30.8

Every figure above is read from this page's own data on each daily rebuild. Informational only, not financial advice. As of October 21, 2026.

Related Medical Devices Stocks

ABT

Abbott Laboratories

$173.92B

 MDT

Medtronic plc.

$119.00B

 SYK

Stryker Corporation

$114.15B

 BSX

Boston Scientific Corporation

$64.33B

 EW

Edwards Lifesciences Corporation

$50.95B

 GEHC

GE HealthCare Technologies Inc.

$31.17B
View all Medical Devices stocks →

Popular Healthcare Stocks

LLY

Eli Lilly and Company

$1.13T

 JNJ

Johnson & Johnson

$621.22B

 ABBV

AbbVie Inc.

$503.27B

 UNH

UnitedHealth Group Incorporated

$374.30B

 MRK

Merck & Co., Inc.

$369.78B
View all Healthcare stocks →

About Nuwellis, Inc.

Nuwellis, Inc., a medical device company, develops, manufactures, and commercializes medical devices used in ultrafiltration therapy. The company provides Aquadex FlexFlow and Aquadex SmartFlow systems, which are used to treat patients suffering from fluid overload due to heart failure, as well as Aquadex SmartFlow system for temporary use in adult and pediatric patients. The company was formerly known as CHF Solutions, Inc. and changed its name to Nuwellis, Inc. in April 2021. Nuwellis, Inc. was founded in 1999 and is headquartered in Eden Prairie, Minnesota.

Visit website →